000 01477 a2200433 4500
005 20250515171357.0
264 0 _c20090707
008 200907s 0 0 eng d
022 _a1526-8209
024 7 _a10.3816/CBC.2009.n.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChin, Sheray N
245 0 0 _aPrevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer.
_h[electronic resource]
260 _bClinical breast cancer
_cMay 2009
300 _a108-17 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Hormonal
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCross-Sectional Studies
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aFemale Urogenital Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPostmenopause
650 0 4 _aPrevalence
650 0 4 _aQuality of Life
650 0 4 _aRisk Factors
650 0 4 _aSeverity of Illness Index
650 0 4 _aSurveys and Questionnaires
700 1 _aTrinkaus, Mateya
700 1 _aSimmons, Christine
700 1 _aFlynn, Candi
700 1 _aDranitsaris, George
700 1 _aBolivar, Robyn
700 1 _aClemons, Mark
773 0 _tClinical breast cancer
_gvol. 9
_gno. 2
_gp. 108-17
856 4 0 _uhttps://doi.org/10.3816/CBC.2009.n.020
_zAvailable from publisher's website
999 _c18861294
_d18861294